chronic lymphocytic leukemia
Showing NaN - NaN of 40
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- P-CD19CD20-ALLO1
- Rimiducid
-
La Jolla, California
- +7 more
Aug 25, 2023
Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
-
Birmingham, Alabama
- +795 more
Jan 28, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ublituximab, Umbralisib, Venetoclax)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +49 more
Jan 20, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Obinutuzumab
- +3 more
-
Birmingham, Alabama
- +484 more
Aug 24, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- +3 more
-
Huntsville, Alabama
- +153 more
Aug 19, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in United States (TGR-1202, TGR-1202 + Ublituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
- TGR-1202
- TGR-1202 + Ublituximab
-
Huntsville, Alabama
- +16 more
Jul 20, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Phoenix, Arizona
- +116 more
Jun 27, 2022
Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)
Recruiting
- Lymphoma, B-Cell
- Chronic Lymphocytic Leukemia
- FT596
- +4 more
-
Chicago, Illinois
- +8 more
Jun 21, 2022
Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in Nashville (Patient-reported outcome measure,
Recruiting
- Chronic Myeloid Leukemia
- +3 more
- Patient-reported outcome measure
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 1, 2022
Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)
Completed
- Chronic Lymphocytic Leukemia
-
Huntsville, Alabama
- +87 more
Apr 25, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Chandler, Arizona
- +107 more
Mar 8, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
La Jolla, California
- +91 more
Dec 14, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,
Completed
- Indolent Non-Hodgkin's Lymphoma
- +2 more
- Idelalisib
- +8 more
-
Huntsville, Alabama
- +10 more
Feb 22, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- IPI-145 (duvelisib)
- Ofatumumab
-
La Jolla, California
- +68 more
Mar 15, 2021
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib
Terminated
- Chronic Lymphocytic Leukemia
- +4 more
- Entospletinib MM
- Entospletinib SDD
-
Birmingham, Alabama
- +47 more
Nov 2, 2020
Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Small-Cell Lymphoma
- Ibrutinib
- +2 more
-
La Jolla, California
- +70 more
Aug 27, 2020
Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Completed
- Chronic Lymphocytic Leukemia
-
Pomona, California
- +164 more
May 8, 2020
Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)
Terminated
- Chronic Lymphocytic Leukemia
- Lymphoma, Non-Hodgkin
-
Huntsville, Alabama
- +17 more
Aug 22, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)
Terminated
- Chronic Lymphocytic Leukemia
-
Huntsville, Alabama
- +44 more
Aug 12, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)
Terminated
- Chronic Lymphocytic Leukemia
-
Duarte, California
- +79 more
Aug 5, 2019
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (TG02 citrate)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- TG02 citrate
-
Augusta, Georgia
- +4 more
Jul 23, 2019